arrow_back Back to App

Limiting FDA Innovation Funds for Fiscal Year 2024

This bill proposes to limit the funds available to the Food and Drug Administration (FDA) for innovation in fiscal year 2024. This means less money will be allocated for the development of new drugs and medical technologies, potentially affecting the speed of market introduction and availability of new therapies for citizens.
Key points
The bill caps funds for the FDA Innovation Account at $50 million for fiscal year 2024.
Reduced funding may slow down research and development of new drugs and medical technologies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2297
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2297.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • The bill caps funds for the FDA Innovation Account at $50 million for fiscal year 2024.
  • Reduced funding may slow down research and development of new drugs and medical technologies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health Public Investments